› Forums › General Melanoma Community › Moffitt Cancer Center Researchers Working at Frontiers of Melanoma Research
- This topic has 3 replies, 1 voice, and was last updated 12 years ago by LynnLuc.
- Post
-
- April 27, 2012 at 8:11 pm
Released: 4/27/2012 1:00 PM EDT
Source: Moffitt Cancer CenterReleased: 4/27/2012 1:00 PM EDT
Source: Moffitt Cancer CenterNewswise — TAMPA, Fla. (April 27, 2012) – At Moffitt Cancer Center, patients with stage III and IV unresectable melanoma are now routinely genetically profiled for several gene mutations, including the BRAF gene, a known driver oncogene for melanoma. Research has shown that mutations in the BRAF gene determine sensitivity or resistance to a class of drugs that are BRAF inhibitors.
Moffitt Cancer Center Researchers Working at Frontiers of Melanoma Research
Best Regards,
Jimmy B
Viewing 2 reply threads
- Replies
Viewing 2 reply threads
- You must be logged in to reply to this topic.